Circulating tumour DNA biomarkers in savolitinib-treated patients with non-small cell lung cancer harbouring MET exon 14 skipping alterations: a post hoc analysis of a pivotal phase 2 study.
Yongfeng YuYongxin RenJian FangLejie CaoZongan LiangQisen GuoSen HanZimei JiYe WangYulan SunYuan ChenXingya LiHua XuJianying ZhouLiyan JiangYing ChengZhigang HanJianhua ShiGongyan ChenRui MaYun FanSanyuan SunLongxian JiaoXiaoyun JiaLinfang WangPuhan LuQian XuXian LuoWeiguo SuShun LuPublished in: Therapeutic advances in medical oncology (2022)
The trial was registered with ClinicalTrials.gov (NCT02897479) on 13 September 2016.